BRIEF-Noble Midstream Partners increases quarterly distribution
* Noble Midstream Partners Lp - distribution represents a 4.7% increase over Q4 2016 distribution of $0.3925 per unit
March 28 Sanofi SA :
* Regeneron and Sanofi announce FDA approval of Dupixent® (Dupilumab), the first targeted biologic therapy for adults with moderate-to-severe atopic dermatitis
* Dupixent is expected to be available to patients and providers in U.S. later this week
* Regeneron and Sanofi Genzyme, specialty care global business unit of Sanofi, will market Dupixent in United States Source text for Eikon: Further company coverage:
MEXICO CITY, April 27 A probe by Mexico's antitrust authority into alleged price manipulation in the market for government bonds is "credit negative" for banks, which are the biggest intermediaries of government paper, Moody's Investors Service said on Thursday.
* Wilh. Wilhelmsen Holding ASA: Wilhelmsen acquires Drew Marine Technical